Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BONESUPPORT HOLDING AB ( (SE:BONEX) ) has issued an announcement.
BONESUPPORT Holding AB will publish its year-end report for the fourth quarter of 2025 on February 24, with management set to present the results during a conference call and webcast later that morning. The English-language presentation, led by CEO Torbjörn Sköld and CFO Håkan Johansson, will allow stakeholders to submit questions via both webcast and teleconference, underscoring the company’s focus on transparency and investor engagement around its financial performance.
The most recent analyst rating on (SE:BONEX) stock is a Buy with a SEK199.00 price target. To see the full list of analyst forecasts on BONESUPPORT HOLDING AB stock, see the SE:BONEX Stock Forecast page.
More about BONESUPPORT HOLDING AB
BONESUPPORT Holding AB is a Swedish medical technology company specializing in orthobiologics for treating bone injuries. Listed on Nasdaq Stockholm under the ticker BONEX, it develops and commercializes innovative injectable bio-ceramic bone graft substitutes based on its patented CERAMENT platform, with products designed to remodel into the patient’s own bone and deliver drugs, generating net sales of SEK 899 million in 2024.
YTD Price Performance: -3.83%
Average Trading Volume: 265,490
Technical Sentiment Signal: Hold
Current Market Cap: SEK11.91B
See more insights into BONEX stock on TipRanks’ Stock Analysis page.